GRANITE POINT CAPITAL
Granite Point Capital is a hedge fund. They have closed-end investment office in Boston, MA. Jeffrey Barnett, the chief operating officer of Granite Point Capital in Boston, is responsible for all aspects of the firm's business, including human resources, systems, trading, compliance and risk management. He also serves on the firm's investment committee, and has been instrumental in crafting a number of its investments in private equity transactions. Launched in February of 2004, Granite Point Capital is a research-driven, long/short equity hedge fund with a global mandate and a focus on mid-small cap US equities. Although primarily focused on the public markets, it has invested in a number of PIPEs, private equity and venture-backed companies.
GRANITE POINT CAPITAL
Founded:
2005-01-01
Status:
Active
Contact:
617.587.7500
Email Addresses:
[email protected]
Technology used in webpage:
SPF SSL By Default Apache Amazon GoDaddy DNS Google Google Cloud Amazon Virginia Region Google Cloud Global Multi-Region Google Cloud CDN
Similar Organizations
Apricot Capital
Apricot Capital is a seed stage investment firm based in Boston, MA and Toronto, Canada.
Block Dream Fund
Block Dream Fund operates as an investment institution.
Swiss Founders Fund
Swiss Founders Fund is a seed and early stage investment fund based in Switzerland.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-28 | Cerebral Therapeutics | Granite Point Capital investment in Series C - Cerebral Therapeutics | 40 M USD |
| 2022-04-07 | Receptor Life Sciences | Granite Point Capital investment in Series A - Receptor Life Sciences | 9.7 M USD |
| 2021-11-03 | Antios Therapeutics | Granite Point Capital investment in Series B - Antios Therapeutics | 75 M USD |
| 2021-07-15 | Teikametrics | Granite Point Capital investment in Series B - Teikametrics | 40 M USD |
| 2021-04-12 | Antios Therapeutics | Granite Point Capital investment in Series B - Antios Therapeutics | 96 M USD |
| 2020-02-20 | Teikametrics | Granite Point Capital investment in Venture Round - Teikametrics | 15 M USD |
| 2020-01-06 | Cerebral Therapeutics | Granite Point Capital investment in Series B - Cerebral Therapeutics | 35 M USD |
| 2019-03-08 | Cerebral Therapeutics | Granite Point Capital investment in Series A - Cerebral Therapeutics | 7.8 M USD |
| 2018-10-25 | Teikametrics | Granite Point Capital investment in Series A - Teikametrics | 10 M USD |
| 2018-06-20 | Cerebral Therapeutics | Granite Point Capital investment in Series A - Cerebral Therapeutics | 3 M USD |